Paper and pharmaceutical lobbies are clashing over rules to digitize drug information leaflets which ensure up-to-date information while also cutting emissions and waste.
Former Rep. <b></b>Filemon<b> </b>Vela will be lobbying for the Port of Corpus Christi Authority on transportation and infrastructure issues, according to a lobbying disclosure filed last week.
Updated
Presented by
With Daniel Lippman
PHARMACEUTICAL COALITION HITS PINGREE, GOLDEN IN ESCALATING E-LABELING FIGHT: A coalition of drugmakers announced a new ad buy today as the lobbying battle about an obscure FDA spending rider moves to the House floor. The
Alliance to Modernize Prescribing Information, whose members include
AbbVie, AmerisourceBergen, Johnson & Johnson, Merck, Bristol Myers Squibb, Viatris, Pfizer and
Teva, announced a 30-second ad targeting Maine Democrats
Jared Golden, whom the group accuses of blocking the FDA from allowing pharmacists to opt out of the paper pamphlets of prescribing information. Congressional appropriators have included a rider in every spending bill since 2015 barring the FDA from carrying out a proposed rule to allow prescribing information to be distributed digitally rather than on paper. Back in April, a bipartisan group of House members wrote to Appropriations Chair